| 中文名称: | 反式-4-(4-(环丙基甲基)哌嗪-1-基)环己基胺三盐酸盐 |
| 中文别名: | 4-[4-(环丙基甲基)-1-哌嗪基]-环己胺三盐酸盐;反式-4-[4-(环丙基甲基)-1-哌嗪]-环己胺 三盐酸盐;反式-环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-,(盐酸)(1:3) |
| smiles: | Cl[H].Cl[H].Cl[H].N1(C([H])([H])C([H])([H])N(C([H])([H])C1([H])[H])C([H])([H])C1([H])C([H])([H])C1([H])[H])C1([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])N([H])[H] |
| 英文名称: | trans-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexanamine trihydrochloride |
| 英文别名: | Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-, trihydrochloride, trans-;CYCLOHEXANAMINE, 4-[4-(CYCLOPROPYLMETHYL)-1-PIPERAZINYL]-, HYDROCHLORIDE (1:3), TRANS-;Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-,trihydrochloride, trans-;trans-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexanamine trih ydrochloride;trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]-cyclohexanamine trihydrochloride;trans-4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexanamine trihydrochloride;Cyclohexanamine,4-[4-(cyclopropylmethyl)-1-piperazinyl]-,trihydrochloride,trans-;trans-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexanamine trihydrochloride;BCP12452;trans-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexanamine trihydrochloride;SB17643;(1R,4R)-4-[4-(CYCLOPROPYLMETHYL)PIPERAZIN-1-YL]CYCLOHEXAN-1-AMINE TRIHYDROCHLORIDE;4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexan-1-amine;trihydrochloride;trans-4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexanamine 3HCl;CS-0000961;AS-73437;AKOS027257186;W17163;882660-42-6;trans-4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexanaminetrihydrochloride |
| CAS号: | 882660-42-6 |
| 分子式: | C14H30CL3N3 |
| 分子量: | 346.77 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
反式-4-(4-(环丙基甲基)哌嗪-1-基)环己基胺三盐酸盐
英文名:
trans-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexanamine trihydrochloride
别名:4-[4-(环丙基甲基)-1-哌嗪基]-环己胺三盐酸盐;反式-4-[4-(环丙基甲基)-1-哌嗪]-环己胺 三盐酸盐;反式-环己胺,4-[4-(环丙基甲基)-1-哌嗪基]-,(盐酸)(1:3)
商品编号:R119271-250mg
规格:250mg
纯度:95%
CAS号: 882660-42-6
分子式:C14H30CL3N3
分子量:346.77
| 价格 |
¥ 740.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















